Biomaterial Wound Dressing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027, Segmented By Product (Alginate Dressing, Hydrocolloids, Skin Substitutes, Others), By Type (Primary Vs. Secondary), By Application (Wounds, Burns, Ulcers, Others), By End Users (Hospitals & Clinics, Ambulatory Surgical Centers, Homecare), By Region

Global biomaterial Wound Dressing market is expected to grow at a CAGR of 7.36% and reach USD2500.52 million in 2027. This can be attributed to the increase in trauma cases and burns and the prevalence of wound injuries. Treatment costs for chronic and acute wounds are rising, putting pressure on healthcare systems. The average cost per patient-year for patients who had amputations due to ulcers, for example, was USD 3,538.17, according to a paper published in CIMS Endocrinology (February 2021). Minor and major amputations cost an average of USD 10,997.52 and USD 31,655.37 per patient-year, respectively. Diabetes care cost SGD 1 billion in 2010, according to data published in the Singapore Medical Association (2018), and this value is predicted to rise to SGD 2.5 billion by 2050. As a result, patients increasingly need cost-effective and innovative treatments.

Introduction of Innovative & Advanced Wound Products Increases the Demand for Biomaterial Wound Dressing

Faster healing, a lesser risk of infection, and painless dressing removal are all benefits of using advanced wound dressings, which contain antimicrobial or wound healing ingredients that are 50% more effective. Additionally, they offer better cosmetic results with fewer scars, save money, and can take the place of conventional wound dressings. Due to their capacity to effectively manage chronic wounds and burn injuries by restoring tissue integrity, obviating the need for frequent doctor visits for dressing changes, ensuring improved clinical patient outcomes non-invasively, and resulting in minimal scarring, and biologics have recently grown in popularity in advanced wound care. Growth factors and artificial skin substitutes are often employed as biologics in wound care.   

Increase Prevalence of Chronic Diseases Fuel the Demand for Biomaterial Wound Dressing

As the prevalence of chronic diseases like diabetes, cancer, and other autoimmune disorders rises globally, chronic wounds are predicted to become increasingly prevalent. The growth in the prevalence of non-communicable diseases is attributed to factors such as antimicrobial resistance, unhealthy, sedentary lifestyles, and cigarette and alcohol use. The CDC's National Diabetes Statistics report states that as of 2020, there were an estimated 34.2 million people with diabetes, or close to 10% of the population. Similar studies indicate that there are 26.8 million persons with diabetes who have received a diagnosis and another 7.3 million who have the disease but have not yet received a diagnosis.

Rising Geriatric Population to Drive Global Biomaterial Wound Dressing Market

Chronic conditions that affect skin integrity, like diabetes and peripheral vascular disease (venous hypertension, arterial insufficiency), are on the rise as the number of seniors increases. These infections are anticipated to cause skin breakdown, ulceration, and the development of recurrent sores. The aged also have a higher risk of infection and a compromised immune system, which makes wound treatment more difficult and calls for advanced wound care options, especially for severe wounds. The age group of Americans' general population that is now expanding at the quickest rate is those over 65. Of 2060, roughly one in four Americans, according to the National Population Projections by the U.S. Census Bureau for 2017, will likely be older adults.

 Increasing Number of Surgeries also boost the Biomaterial Wound Dressing Market

The number of procedures is growing because of the prevalence of chronic diseases. Around 18 million Americans underwent minimally invasive cosmetic surgery in 2018, according to the American Society of Plastic Surgeons. Advanced wound care techniques are therefore being applied more frequently to prevent surgical site infections. After cancer surgery, the majority of surgical wounds are large and deep, producing exudates that require ongoing management. Large wounds can be managed, and the danger of infection is reduced with the help of wound care products including hydrogel, alginate, and foam.

Market Segmentation

The global biomaterial Wound Dressing market is segmented based on product, type, application, end users, region and company. Based on product, the global biomaterial Wound Dressing market can be split into alginate dressing, hydrocolloids, skin substitutes and others. Based on type, it can be further categorized into primary, secondary. Based on application, the global biomaterial Wound Dressing market can be segmented into wounds, burns, ulcers, and others. Based on end user, the market is segmented into hospitals & clinics, ambulatory surgical centers, and homecare. Regionally, the global biomaterial Wound Dressing market can be categorized into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America dominates the overall global biomaterial Wound Dressing market with United States having the biggest market.

 The United States Biomaterial Wound Dressing market is expected to grow at a CAGR of 8.18% and reach 720.65 million in 2027.

Company Profiles

Major companies in the market are Smith & Nephew plc, Molnlycke Health Care AB, Integra LifeSciences Holdings Corporation, Convatec Group plc, 3M Company, Medtronic plc, Johnson & Johnson, Hollister Incorporated, B. Braun Melsungen AG., and DermaRite Industries LLC. Major players operating in the market are following strategies such as mergers and acquisitions, new therapy, among others, in order to stay competitive and have an edge over other players in the market.

Report Scope:

In this report, global biomaterial Wound Dressing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

·         Global Biomaterial Wound Dressing Market, By Product:

• Alginate Dressing
• Hydrocolloids
• Skin Substitutes
• Others

·         Global Biomaterial Wound Dressing Market, By Type:

• Primary
• Secondary

·         Global Biomaterial Wound Dressing Market, By Application:

• Wounds
• Burns
• Ulcers
• Others
• Global Biomaterial Wound Dressing Market, By End User:
• Hospitals & Clinics
• Ambulatory Surgical Centers (ASC)
• Homecare
• Global Biomaterial Wound Dressing Market, By Region:
• North America
• United States
• Canada
• Mexico
• Europe
• Germany
• United Kingdom
• France
• Italy
• Spain
• Asia Pacific
• China
• Japan
• India
• South Korea
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE 

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global biomaterial Wound Dressing market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).